Holocene Advisors LP Has $5.18 Million Stock Holdings in Teleflex Incorporated (NYSE:TFX)

Holocene Advisors LP trimmed its stake in Teleflex Incorporated (NYSE:TFX) by 1.4% in the third quarter, HoldingsChannel reports. The firm owned 20,925 shares of the medical technology company’s stock after selling 295 shares during the period. Holocene Advisors LP’s holdings in Teleflex were worth $5,175,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in TFX. DekaBank Deutsche Girozentrale lifted its stake in shares of Teleflex by 2.5% in the first quarter. DekaBank Deutsche Girozentrale now owns 7,290 shares of the medical technology company’s stock valued at $1,606,000 after buying an additional 180 shares in the last quarter. DNB Asset Management AS raised its position in Teleflex by 5.2% in the second quarter. DNB Asset Management AS now owns 7,584 shares of the medical technology company’s stock worth $1,595,000 after acquiring an additional 376 shares during the period. CWM LLC raised its position in Teleflex by 22.9% in the second quarter. CWM LLC now owns 1,317 shares of the medical technology company’s stock worth $277,000 after acquiring an additional 245 shares during the period. BDF Gestion bought a new stake in Teleflex in the second quarter worth about $1,559,000. Finally, Opal Wealth Advisors LLC raised its position in Teleflex by 14.1% in the second quarter. Opal Wealth Advisors LLC now owns 714 shares of the medical technology company’s stock worth $150,000 after acquiring an additional 88 shares during the period. 95.62% of the stock is owned by institutional investors.

Analyst Ratings Changes

TFX has been the subject of several recent research reports. Truist Financial reiterated a “hold” rating and issued a $227.00 target price (down previously from $255.00) on shares of Teleflex in a research note on Monday, November 4th. Mizuho dropped their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Friday, November 1st. Finally, StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $259.00.

Teleflex Stock Down 0.4 %

Shares of Teleflex stock opened at $187.33 on Thursday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company’s fifty day simple moving average is $216.58 and its two-hundred day simple moving average is $221.81. The company has a market cap of $8.70 billion, a P/E ratio of 37.24, a PEG ratio of 1.99 and a beta of 1.16. Teleflex Incorporated has a 12-month low of $185.27 and a 12-month high of $257.85.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. The firm had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company’s revenue was up 2.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.64 EPS. Research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Friday, November 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.73%. The ex-dividend date is Friday, November 15th. Teleflex’s dividend payout ratio (DPR) is 27.04%.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.